Skip to main content
Search

* All fields must be filled out.

Send message!
Search

Long‑term remission of prostate cancer with extensive bone metastases upon immuno‑ and virotherapy: A case report

Abstract

The present study reports the case of a patient with hormone-refractory metastatic prostate cancer who had failed standard therapy, but then achieved complete remission following combined treatment with local hyperthermia (LHT), Newcastle disease virus and dendritic cell (DC) vaccination, which was an unusual combination. In August 2005, the patient underwent a radical prostatectomy. Despite standard treatment, the patient developed progressive bone metastases and stopped conventional therapy in June 2007. Starting in October 2007, the patient was treated with LHT, oncolytic virotherapy and DC vaccination. Prostate‑specific antigen (PSA)-levels, with the highest level of 233.8 ng/ml in January 2008, decreased to 0.8 ng/ml in late February 2008. In March 2008, a reduction in bone metastases could be detected by positron emission tomography/computed tomography. Since then, the PSA levels have remained low and the patient is doing well. The treatment induced a long-lasting antitumor memory T-cell response. This possibly explains the long-term effectiveness of this novel experimental combined treatment approach.

Year
2014
Author
Volker Schirrmacher,
Akos-Sigmund Bihari,
Wilfried Stücker,
Tobias Sprenger
Indication
Prostate
Publication type
Therapy
SRG+CT+mEHT
Evidence
No. of patients
1